查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1937023

全球番紅花素市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global CROCIN Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計藏紅花素市場規模將從 2025 年的 60.5 億美元成長到 2034 年的 99.8 億美元，2026 年至 2034 年的複合年成長率為 5.72%。

番紅花素市場（涵蓋番紅花素這種藥物化合物的生產和銷售）正經歷顯著成長，這主要歸因於發燒和疼痛相關疾病的增加。番紅花素以對乙醯胺酚為基礎，因其有效的止痛退燒功效而聞名，廣泛應用於家庭和醫療機構。隨著人們健康意識的不斷提高，消費者擴大選擇番紅花素等非處方藥來快速緩解常見症狀。這一趨勢正在推動對番紅花素產品的需求，預計未來幾年市場將穩定成長。

此外，消費者對預防醫學日益成長的興趣也影響著番紅花素市場，因為他們正在尋求針對各種疾病的有效治療方案。尤其是在發展中地區，自我治療的日益普及推動了番紅花素及類似產品的銷售成長。由於醫療保健系統在提供及時護理方面面臨挑戰，因此，有效非處方藥的供應至關重要。為了因應這一趨勢，製造商正在拓展產品線，專注於開發滿足特定消費者需求的配方，例如兒童配方和針對多種疾病的複方製劑。

此外，醫藥產業的數位轉型正在重塑番紅花素市場。電子商務平台和遠端醫療服務讓消費者足不出戶即可輕鬆取得包括番紅花素在內的藥品。在新冠疫情的背景下，這項轉變尤其重要，疫情加速了線上醫療解決方案的普及。隨著市場的不斷發展，在健康意識的提高、自我治療的盛行以及數位化分銷管道的成長的推動下，番紅花素市場預計將持續成長。市場將持續發展，以滿足消費者對有效緩解疼痛和退燒的多樣化需求。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球藏紅花素市場按應用領域分類

  • 市場分析、洞察與預測
  • 食物
  • 化工
  • 製藥
  • 其他

5. 全球藏紅花素市場（依純度分類）

  • 市場分析、洞察與預測
  • 純度：98%或以上
  • 純度

6. 全球番紅花素市場依適應症分類

  • 市場分析、洞察與預測
  • 疼痛
  • 發熱）

7. 全球藏紅花素市場按分銷管道分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 其他

8. 全球藏紅花素市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • TCI Chemicals Pvt. Ltd
    • Merck KGaA
    • GSK Plc
    • Cayman Chemical
    • APExBIO Technology
    • Wilshire Technologies
    • Biosynth
    • Cipla Inc
    • Novartis AG
    • Sanofi
    • Aurobindo Pharma
    • Teva Pharmaceutical Industries Ltd
    • Mallinckrodt
簡介目錄
Product Code: VMR11214564

The CROCIN Market size is expected to reach USD 9.98 Billion in 2034 from USD 6.05 Billion (2025) growing at a CAGR of 5.72% during 2026-2034.

The CROCIN market, which encompasses the production and distribution of the pharmaceutical compound Crocin, is witnessing significant growth due to the increasing prevalence of fever and pain-related ailments. Crocin, known for its efficacy as a paracetamol-based analgesic and antipyretic, is widely used in households and healthcare settings. As awareness of health and wellness continues to rise, consumers are increasingly turning to over-the-counter medications like Crocin for quick relief from common ailments. This trend is driving demand for Crocin products, positioning the market for robust expansion in the coming years.

Moreover, the growing emphasis on preventive healthcare is influencing the CROCIN market, as consumers seek effective solutions for managing symptoms associated with various conditions. The rise of self-medication, particularly in developing regions, is contributing to increased sales of Crocin and similar products. As healthcare systems face challenges in providing timely access to medical care, the availability of effective over-the-counter medications becomes crucial. This trend is prompting manufacturers to enhance their product offerings, focusing on formulations that cater to specific consumer needs, such as pediatric formulations and combination products that address multiple symptoms.

Additionally, the digital transformation of the pharmaceutical industry is reshaping the CROCIN market. E-commerce platforms and telemedicine services are making it easier for consumers to access medications, including Crocin, from the comfort of their homes. This shift is particularly relevant in the wake of the COVID-19 pandemic, which has accelerated the adoption of online healthcare solutions. As the market continues to evolve, the combination of increasing health awareness, the rise of self-medication, and the growth of digital distribution channels positions the CROCIN market for sustained growth, meeting the diverse needs of consumers seeking effective pain and fever relief.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Food
  • Chemical Industry
  • Drug
  • Others

By Purity

  • Purity >98%
  • Purity

By Indication

  • Pain
  • Pyrexia (Fever)

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

COMPANIES PROFILED

  • TCI Chemicals Pvt Ltd, Merck KGaA, GSK plc, Cayman Chemical, APExBIO Technology, Wilshire Technologies, Biosynth, Cipla Inc, Novartis AG, Sanofi, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CROCIN MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Food Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Chemical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CROCIN MARKET: BY PURITY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Purity
  • 5.2. Purity >98% Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Purity

Chapter 6. GLOBAL CROCIN MARKET: BY INDICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Indication
  • 6.2. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pyrexia (Fever) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CROCIN MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CROCIN MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Application
    • 8.2.2 By Purity
    • 8.2.3 By Indication
    • 8.2.4 By Distribution Channel
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Application
    • 8.3.2 By Purity
    • 8.3.3 By Indication
    • 8.3.4 By Distribution Channel
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Application
    • 8.4.2 By Purity
    • 8.4.3 By Indication
    • 8.4.4 By Distribution Channel
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Application
    • 8.5.2 By Purity
    • 8.5.3 By Indication
    • 8.5.4 By Distribution Channel
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Application
    • 8.6.2 By Purity
    • 8.6.3 By Indication
    • 8.6.4 By Distribution Channel
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CROCIN INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 TCI Chemicals Pvt. Ltd
    • 10.2.2 Merck KGaA
    • 10.2.3 GSK Plc
    • 10.2.4 Cayman Chemical
    • 10.2.5 APExBIO Technology
    • 10.2.6 Wilshire Technologies
    • 10.2.7 Biosynth
    • 10.2.8 Cipla Inc
    • 10.2.9 Novartis AG
    • 10.2.10 Sanofi
    • 10.2.11 Aurobindo Pharma
    • 10.2.12 Teva Pharmaceutical Industries Ltd
    • 10.2.13 Mallinckrodt